应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02160 心通医疗-B
休市中 08-23 16:08:27
0.610
-0.030
-4.69%
最高
0.650
最低
0.600
成交量
781.00万
今开
0.640
昨收
0.640
日振幅
7.81%
总市值
14.72亿
流通市值
14.72亿
总股本
24.13亿
成交额
476.81万
换手率
0.32%
流通股本
24.13亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
心通医疗-B盘中异动 股价大跌6.25%报0.600港元
市场透视 · 08-23 10:57
心通医疗-B盘中异动 股价大跌6.25%报0.600港元
心通医疗-B(02160)下跌6.25%,报0.6元/股
金融界 · 08-23 10:57
心通医疗-B(02160)下跌6.25%,报0.6元/股
心通医疗-B(02160)股价下跌6.25%,现价港币$0.6
阿斯达克财经 · 08-23 10:57
心通医疗-B(02160)股价下跌6.25%,现价港币$0.6
心通医疗(02160.HK)向微创医疗(00853.HK)购上海工业基地
阿斯达克财经 · 08-23 10:09
心通医疗(02160.HK)向微创医疗(00853.HK)购上海工业基地
心通医疗-B拟向微创医疗收购上海物业作为集团的全球总部
新浪港股 · 08-23 07:17
心通医疗-B拟向微创医疗收购上海物业作为集团的全球总部
心通医疗-B(02160)拟向微创医疗(00853)收购上海物业作为集团的全球总部
智通财经网 · 08-22 23:05
心通医疗-B(02160)拟向微创医疗(00853)收购上海物业作为集团的全球总部
心通医疗-B08月22日遭主力抛售26万元 环比增加2500.00%
市场透视 · 08-22 16:15
心通医疗-B08月22日遭主力抛售26万元 环比增加2500.00%
首个“中国智造”心脏主动脉瓣膜系统进入欧洲
解放日报 · 08-21
首个“中国智造”心脏主动脉瓣膜系统进入欧洲
心通医疗-B(02160)下跌5.71%,报0.66元/股
金融界 · 08-20
心通医疗-B(02160)下跌5.71%,报0.66元/股
心通医疗-B盘中异动 急速下跌5.71%报0.660港元
自选股智能写手 · 08-20
心通医疗-B盘中异动 急速下跌5.71%报0.660港元
心通医疗(02160)被剔除出恒生综合小型股指数 或将被移出港股通
智通财经 · 08-16
心通医疗(02160)被剔除出恒生综合小型股指数 或将被移出港股通
心通医疗-B(02160.HK)拟8月28日举行董事会会议批准中期业绩
格隆汇 · 08-14
心通医疗-B(02160.HK)拟8月28日举行董事会会议批准中期业绩
心通医疗-B盘中异动 早盘急速上涨5.56%
自选股智能写手 · 08-06
心通医疗-B盘中异动 早盘急速上涨5.56%
心通医疗-B(02160)下跌5.33%,报0.71元/股
金融界 · 08-05
心通医疗-B(02160)下跌5.33%,报0.71元/股
心通医疗-B盘中异动 下午盘股价大跌5.33%报0.710港元
自选股智能写手 · 08-05
心通医疗-B盘中异动 下午盘股价大跌5.33%报0.710港元
心通医疗-B(02160)股价下跌5.333%,现价港币$0.71
阿斯达克财经 · 08-05
心通医疗-B(02160)股价下跌5.333%,现价港币$0.71
南向资金8月1日净卖出心通医疗-B218.20万股 连续7日减持
自选股智能写手 · 08-02
南向资金8月1日净卖出心通医疗-B218.20万股 连续7日减持
心通医疗-B盘中异动 大幅上涨5.41%报0.780港元
自选股智能写手 · 08-01
心通医疗-B盘中异动 大幅上涨5.41%报0.780港元
心通医疗-B(02160)股价上升5.634%,现价港币$0.75
阿斯达克财经 · 07-31
心通医疗-B(02160)股价上升5.634%,现价港币$0.75
心通医疗-B(02160)上涨5.63%,报0.75元/股
金融界 · 07-31
心通医疗-B(02160)上涨5.63%,报0.75元/股
加载更多
公司概况
公司名称:
心通医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
微创心通医疗科技有限公司是一家主要从事医疗器械行业的中国投资控股公司。该公司主要从事心脏瓣膜疾病领域经导管及手术解决方案的研发和商业化。该公司主要产品包括第一代经导管主动脉瓣植入(TAVI)产 品“VitaFlow”和第二代TAVI产品“VitaFlow II”。该公司主要于国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02160","market":"HK","secType":"STK","nameCN":"心通医疗-B","latestPrice":0.61,"timestamp":1724400507031,"preClose":0.64,"halted":0,"volume":7810000,"delay":0,"floatShares":2412592839,"shares":2412592839,"eps":-0.21867876,"marketStatus":"休市中","marketStatusCode":7,"change":-0.03,"latestTime":"08-23 16:08:27","open":0.64,"high":0.65,"low":0.6,"amount":4768070,"amplitude":0.078125,"askPrice":0.61,"askSize":292000,"bidPrice":0.6,"bidSize":106000,"shortable":3,"etf":0,"ttmEps":-0.21867876179412618,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"listingDate":1612368000000,"adjPreClose":0.64,"openAndCloseTimeList":[[1724376600000,1724385600000],[1724389200000,1724400000000]],"volumeRatio":1.6455759039063171,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02160","defaultTab":"news","newsList":[{"id":"2461758959","title":"心通医疗-B盘中异动 股价大跌6.25%报0.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461758959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461758959?lang=zh_cn&edition=full","pubTime":"2024-08-23 10:57","pubTimestamp":1724381838,"startTime":"0","endTime":"0","summary":"2024年08月23日早盘10时57分,心通医疗-B股票出现波动,股价大幅下跌6.25%。截至发稿,该股报0.600港元/股,成交量199万股,换手率0.08%,振幅7.81%。资金方面,该股资金流入56.411万港元,流出57.26万港元。心通医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.07%。据悉,目标公司成立的唯一目的为用作自上海微创医疗收购及持有目标物业的工具。目标公司目前的账面值为人民币10,000元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082310571997199b55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082310571997199b55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02160","BK1574","BK1583","BK1100"],"gpt_icon":0},{"id":"2461586195","title":"心通医疗-B(02160)下跌6.25%,报0.6元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2461586195","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461586195?lang=zh_cn&edition=full","pubTime":"2024-08-23 10:57","pubTimestamp":1724381836,"startTime":"0","endTime":"0","summary":"8月23日,心通医疗-B盘中下跌6.25%,截至10:57,报0.6元/股,成交122.72万元。心通医疗是一家中国领先的医疗器械企业,主要从事结构性心脏病领域的经导管和手术解决方案的研发和商业化,产品包括VitaFlow系列经导管主动脉瓣植入产品、经导管二尖瓣治疗产品、经导管三尖瓣治疗产品、外科瓣膜产品和手术配件等。截至2023年年报,心通医疗-B营业总收入3.36亿元、净利润-4.72亿元。8月28日,心通医疗-B将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/23105742641746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1100","BK1583","02160","BK1574"],"gpt_icon":0},{"id":"2461589625","title":"心通医疗-B(02160)股价下跌6.25%,现价港币$0.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2461589625","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461589625?lang=zh_cn&edition=full","pubTime":"2024-08-23 10:57","pubTimestamp":1724381820,"startTime":"0","endTime":"0","summary":"[下跌股]心通医疗-B(02160) 股价在上午10:57比前收市价下跌6.25%,现股价为港币$0.6。至目前为止,今日最高价为$0.65,而最低价为$0.6。总成交量为199万股,总成交金额为港币$122.716万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240823762/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1100","BK1574","02160"],"gpt_icon":0},{"id":"2461583981","title":"心通医疗(02160.HK)向微创医疗(00853.HK)购上海工业基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2461583981","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461583981?lang=zh_cn&edition=full","pubTime":"2024-08-23 10:09","pubTimestamp":1724378940,"startTime":"0","endTime":"0","summary":"心通医疗公布关连交易,其全资附属上海微创心通,向微创医疗的全资附属上海微创医疗,收购目标公司上海心永医疗科技的全部股权。目标公司持有一幅位于上海市浦东新区张江科学城牛顿路501号面积为13,320平方米的土地的国有土地使用权,以及该地块上所建三幢总建筑面积为8,781.03平方米的楼宇及73个停车位。微创医疗透过其全资附属Shanghai MicroPort间接持有心通医疗已发行股本总额约46.13%。沽空资料截至 2024-08-22 16:25。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220906143937713_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220906143937713_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1374410/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1100","BK1589","BK1583","BK1585","02160","00853","BK1574"],"gpt_icon":0},{"id":"2461308850","title":"心通医疗-B拟向微创医疗收购上海物业作为集团的全球总部","url":"https://stock-news.laohu8.com/highlight/detail?id=2461308850","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461308850?lang=zh_cn&edition=full","pubTime":"2024-08-23 07:17","pubTimestamp":1724368626,"startTime":"0","endTime":"0","summary":"心通医疗-B公布,于2024年8月22日,公司的全资附属上海微创心通与微创医疗全资附属上海微创医疗订立股权转让协议,上海微创心通拟向上海微创医疗收购上海心永医疗科技有限公司的全部股权,代价不应超过人民币3.8亿元。 据悉,目标公司成立的唯一目的为用作自上海微创医疗收购及持有目标物业的工具。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-08-23/doc-inckqshv8364218.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-08-23/doc-inckqshv8364218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1258","BK1589","BK1574","BK1229","BK1585","03913","BK1100","BK1583","02160","00853","BK1542"],"gpt_icon":0},{"id":"2461341866","title":"心通医疗-B(02160)拟向微创医疗(00853)收购上海物业作为集团的全球总部","url":"https://stock-news.laohu8.com/highlight/detail?id=2461341866","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461341866?lang=zh_cn&edition=full","pubTime":"2024-08-22 23:05","pubTimestamp":1724339101,"startTime":"0","endTime":"0","summary":"心通医疗-B(02160)公布,于2024年8月22日,公司的全资附属上海微创心通...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_42.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_42.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1169012.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","BK1542","BK1258","BK1574","BK1100","BK1229","00853","BK1589","03913","BK1585","02160"],"gpt_icon":0},{"id":"2461364920","title":"心通医疗-B08月22日遭主力抛售26万元 环比增加2500.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461364920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461364920?lang=zh_cn&edition=full","pubTime":"2024-08-22 16:15","pubTimestamp":1724314544,"startTime":"0","endTime":"0","summary":"08月22日, 心通医疗-B股价跌3.03%,报收0.64元,成交金额274万元,换手率0.17%,振幅7.58%,量比1.02。心通医疗-B今日主力资金净流出26万元,上一交易日主力净流出1万元,今日环比增加2500.00%。该股近5个交易日下跌11.11%,主力资金累计净流出57万元;近20日主力资金累计净流出159万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082216164695b34352&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082216164695b34352&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02160","BK1100","BK1574"],"gpt_icon":0},{"id":"2461830351","title":"首个“中国智造”心脏主动脉瓣膜系统进入欧洲","url":"https://stock-news.laohu8.com/highlight/detail?id=2461830351","media":"解放日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461830351?lang=zh_cn&edition=full","pubTime":"2024-08-21 05:37","pubTimestamp":1724189856,"startTime":"0","endTime":"0","summary":"2024年7月4日,由微创心通医疗科技有限公司自主研发的VitaFlow Liberty经导管主动脉瓣膜及可回收输送系统在瑞士最大的医院之一完成欧洲上市后的首例植入,成为首个进入欧洲市场的“中国智造”经导管主动脉瓣植入术产品。其中主动脉瓣的平均厚度只有0.3毫米,每个人的一生主动脉瓣会开合将近20亿次,较易损坏。目前心通医疗的VitaFlow系列TAVI产品及其手术配件Alwide系列球囊导管已进入中国的600余家核心医院,治疗超过1万名主动脉瓣疾病患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082105374095ac038c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082105374095ac038c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1574","02160","BK1583"],"gpt_icon":0},{"id":"2460025421","title":"心通医疗-B(02160)下跌5.71%,报0.66元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2460025421","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460025421?lang=zh_cn&edition=full","pubTime":"2024-08-20 15:40","pubTimestamp":1724139601,"startTime":"0","endTime":"0","summary":"8月20日,心通医疗-B盘中下跌5.71%,截至15:40,报0.66元/股,成交451.75万元。心通医疗是一家中国领先的医疗器械企业,主要从事结构性心脏病领域的经导管和手术解决方案的研发和商业化,产品包括VitaFlow系列经导管主动脉瓣植入产品、经导管二尖瓣治疗产品、经导管三尖瓣治疗产品、外科瓣膜产品和手术配件等。截至2023年年报,心通医疗-B营业总收入3.36亿元、净利润-4.72亿元。8月28日,心通医疗-B将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/20154042516942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1100","BK1583","02160","BK1574"],"gpt_icon":0},{"id":"2460023355","title":"心通医疗-B盘中异动 急速下跌5.71%报0.660港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460023355","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460023355?lang=zh_cn&edition=full","pubTime":"2024-08-20 15:31","pubTimestamp":1724139110,"startTime":"0","endTime":"0","summary":"2024年08月20日临近收盘15时31分,心通医疗-B股票出现异动,股价快速下挫5.71%。截至发稿,该股报0.660港元/股,成交量649万股,换手率0.27%,振幅4.29%。资金方面,该股资金流入144.378万港元,流出196.64万港元。心通医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.15%。其相关个股中,紫元元、佳兆业健康、华检医疗涨幅较大,振幅较大的相关个股有巨星医疗控股、健世科技-B、紫元元,振幅分别为17.14%、16.43%、10.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082015315098e357ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082015315098e357ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02160","BK1583","BK1574","BK1100"],"gpt_icon":0},{"id":"2459171572","title":"心通医疗(02160)被剔除出恒生综合小型股指数 或将被移出港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2459171572","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459171572?lang=zh_cn&edition=full","pubTime":"2024-08-16 21:51","pubTimestamp":1723816307,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,8月16日,恒指公司公布最新季检结果,其中心通医疗被移出恒生综合小型股指数,变动将于2024年9月6日(星期五)收市后实施并于2024年9月9日(星期一)起生效。中金研报指出,心通医疗可能因市值下降、流动性不足或违反相关规定等原因而被移出港股通。近日,心通医疗发布2024H1季度盈警:预期公司2024年上半年取得净亏损约5000万-6500万元,同比收窄约63%至72%。从结果来看,心通医疗当期毛利率已较上年同期提升超过4个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1165791.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","BK1100","HSSI","BK1574","BK1583","HSCEI","YANG","02160"],"gpt_icon":1},{"id":"2459149103","title":"心通医疗-B(02160.HK)拟8月28日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2459149103","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459149103?lang=zh_cn&edition=full","pubTime":"2024-08-14 16:40","pubTimestamp":1723624851,"startTime":"0","endTime":"0","summary":"格隆汇8月14日丨心通医疗-B(02160.HK)宣布,公司将于2024年8月28日(星期三)举行董事会会议,以考虑及批准(其中包括)公司及其附属公司截至2024年6月30日止六个月的中期业绩及其发布,以及派发中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814164051a1d43f67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814164051a1d43f67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1583","BK1574","02160"],"gpt_icon":0},{"id":"2457030452","title":"心通医疗-B盘中异动 早盘急速上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457030452","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457030452?lang=zh_cn&edition=full","pubTime":"2024-08-06 09:51","pubTimestamp":1722909088,"startTime":"0","endTime":"0","summary":"2024年08月06日早盘09时51分,心通医疗-B股票出现异动,股价大幅拉升5.56%。截至发稿,该股报0.760港元/股,成交量132.1万股,换手率0.05%,振幅4.17%。心通医疗-B股票所在的医疗设备及用品行业中,整体涨幅为0.04%。其相关个股中,智云健康、业聚医疗、微创机器人-B涨幅较大,振幅较大的相关个股有中国再生医学、高视医疗、智云健康,振幅分别为11.33%、9.09%、6.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806095128aefd67b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806095128aefd67b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1583","02160","BK1574"],"gpt_icon":0},{"id":"2457790307","title":"心通医疗-B(02160)下跌5.33%,报0.71元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457790307","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457790307?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:36","pubTimestamp":1722836166,"startTime":"0","endTime":"0","summary":"8月5日,心通医疗-B盘中下跌5.33%,截至13:36,报0.71元/股,成交269.09万元。心通医疗是一家中国领先的医疗器械企业,主要从事结构性心脏病领域的经导管和手术解决方案的研发和商业化,产品包括VitaFlow系列经导管主动脉瓣植入产品、经导管二尖瓣治疗产品、经导管三尖瓣治疗产品、外科瓣膜产品和手术配件等。截至2023年年报,心通医疗-B营业总收入3.36亿元、净利润-4.72亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/05133642043162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","BK1100","BK1583","02160"],"gpt_icon":0},{"id":"2457790848","title":"心通医疗-B盘中异动 下午盘股价大跌5.33%报0.710港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457790848","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457790848?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:36","pubTimestamp":1722836161,"startTime":"0","endTime":"0","summary":"2024年08月05日下午盘13时36分,心通医疗-B股票出现波动,股价大幅下挫5.33%。截至发稿,该股报0.710港元/股,成交量363.9万股,换手率0.15%,振幅6.67%。资金方面,该股资金流入65.474万港元,流出178.213万港元。心通医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.13%。其相关个股中,紫元元、加和国际控股、微创脑科学涨幅较大,振幅较大的相关个股有百心安-B、中国卫生集团、智云健康,振幅分别为12.88%、10.29%、8.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080513360196823b1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080513360196823b1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1100","BK1574","02160"],"gpt_icon":0},{"id":"2457579025","title":"心通医疗-B(02160)股价下跌5.333%,现价港币$0.71","url":"https://stock-news.laohu8.com/highlight/detail?id=2457579025","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457579025?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:35","pubTimestamp":1722836100,"startTime":"0","endTime":"0","summary":"[下跌股]心通医疗-B(02160) 股价在下午01:35比前收市价下跌5.333%,现股价为港币$0.71。至目前为止,今日最高价为$0.76,而最低价为$0.71。总成交量为363.9万股,总成交金额为港币$269.093万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2408052329/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1574","02160","BK1100"],"gpt_icon":0},{"id":"2456141904","title":"南向资金8月1日净卖出心通医疗-B218.20万股 连续7日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2456141904","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456141904?lang=zh_cn&edition=full","pubTime":"2024-08-02 09:31","pubTimestamp":1722562296,"startTime":"0","endTime":"0","summary":"8月1日,南向资金减持心通医疗-B218.20万股连续7日减持。截止当日收盘,港股通共持有心通医疗-B19824.80万股,占流通股8.20%。港股通减持金额前五个股分别为中国石油股份、长城汽车、中国神华、比亚迪股份、中国宏桥。心通医疗-B近5个交易日下跌1.30%,港股通累计减持514.40万股;近20个交易日下跌9.52%,港股通累计减持702.70万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080209440295762a15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080209440295762a15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02160","BK1574","BK1583","BK1100"],"gpt_icon":0},{"id":"2456117736","title":"心通医疗-B盘中异动 大幅上涨5.41%报0.780港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456117736","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456117736?lang=zh_cn&edition=full","pubTime":"2024-08-01 09:39","pubTimestamp":1722476396,"startTime":"0","endTime":"0","summary":"2024年08月01日早盘09时39分,心通医疗-B股票出现波动,股价大幅上涨5.41%。截至发稿,该股报0.780港元/股,成交量51.6万股,换手率0.02%,振幅5.41%。资金方面,该股资金流入17.009万港元,流出10.173万港元。心通医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.01%。其相关个股中,智云健康、心通医疗-B、微泰医疗-B涨幅较大,振幅较大的相关个股有智云健康、业聚医疗、高视医疗,振幅分别为7.51%、4.78%、4.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801093957aefc9408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801093957aefc9408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02160","BK1583","BK1100","BK1574"],"gpt_icon":0},{"id":"2455974031","title":"心通医疗-B(02160)股价上升5.634%,现价港币$0.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2455974031","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455974031?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:19","pubTimestamp":1722410340,"startTime":"0","endTime":"0","summary":"[上升股]心通医疗-B(02160) 股价在下午03:19比前收市价上升5.634%,现股价为港币$0.75。至目前为止,今日最高价为$0.76,而最低价为$0.71。总成交量为1.027千万股,总成交金额为港币$754.266万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2407316077/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1100","BK1583","02160","BK1574"],"gpt_icon":0},{"id":"2455092860","title":"心通医疗-B(02160)上涨5.63%,报0.75元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455092860","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455092860?lang=zh_cn&edition=full","pubTime":"2024-07-31 11:32","pubTimestamp":1722396748,"startTime":"0","endTime":"0","summary":"7月31日,心通医疗-B盘中上涨5.63%,截至11:32,报0.75元/股,成交470.42万元。心通医疗是一家中国领先的医疗器械企业,主要从事结构性心脏病领域的经导管和手术解决方案的研发和商业化,产品包括VitaFlow系列经导管主动脉瓣植入产品、经导管二尖瓣治疗产品、经导管三尖瓣治疗产品、外科瓣膜产品和手术配件等。截至2023年年报,心通医疗-B营业总收入3.36亿元、净利润-4.72亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/31113241922052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","02160","BK1100","BK1574"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1528},{"period":"1month","weight":-0.1757},{"period":"3month","weight":-0.4135},{"period":"6month","weight":-0.5612},{"period":"1year","weight":-0.6755},{"period":"ytd","weight":-0.6235}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.0174},{"period":"3month","weight":-0.0536},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0329},{"period":"ytd","weight":0.0331}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微创心通医疗科技有限公司是一家主要从事医疗器械行业的中国投资控股公司。该公司主要从事心脏瓣膜疾病领域经导管及手术解决方案的研发和商业化。该公司主要产品包括第一代经导管主动脉瓣植入(TAVI)产 品“VitaFlow”和第二代TAVI产品“VitaFlow II”。该公司主要于国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.011377},{"month":2,"riseRate":0,"avgChangeRate":-0.108287},{"month":3,"riseRate":0,"avgChangeRate":-0.164923},{"month":4,"riseRate":0.25,"avgChangeRate":0.055893},{"month":5,"riseRate":0.25,"avgChangeRate":-0.107084},{"month":6,"riseRate":0.5,"avgChangeRate":0.027456},{"month":7,"riseRate":0.25,"avgChangeRate":-0.079669},{"month":8,"riseRate":0.25,"avgChangeRate":-0.128549},{"month":9,"riseRate":0,"avgChangeRate":-0.184101},{"month":10,"riseRate":0.666667,"avgChangeRate":0.017935},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.041509},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.071723}],"exchange":"SEHK","name":"心通医疗-B","nameEN":"CARDIOFLOW-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心通医疗-B(02160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心通医疗-B(02160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心通医疗-B,02160,心通医疗-B股票,心通医疗-B股票老虎,心通医疗-B股票老虎国际,心通医疗-B行情,心通医疗-B股票行情,心通医疗-B股价,心通医疗-B股市,心通医疗-B股票价格,心通医疗-B股票交易,心通医疗-B股票购买,心通医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心通医疗-B(02160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心通医疗-B(02160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}